نتایج جستجو برای: hpv vaccines

تعداد نتایج: 68193  

Journal: :Vaccine 2006
Margaret Stanley Douglas R Lowy Ian Frazer

Human papillomavirus virus-like particles (HPV VLP) can be generated by the synthesis and self-assembly in vitro of the major virus capsid protein L1. HPV L1 VLPs are morphologically and antigenically almost identical to native virions, and this technology has been exploited to produce HPV L1 VLP subunit vaccines. The vaccines elicit high titres of anti-L1 VLP antibodies that persist at levels ...

Journal: :Cancer 2008
Maura L Gillison Anil K Chaturvedi Douglas R Lowy

Human papillomavirus (HPV) is a necessary cause of cervical cancer. In addition, on the basis of the fulfillment of a combination of viral as well as epidemiological criteria, it is currently accepted that a proportion of anal, oropharyngeal, vulvar, and vaginal cancers among women and anal, oropharyngeal, and penile cancers among men are etiologically related to HPV. At these noncervical sites...

Journal: :Cancer prevention research 2015
Joshua W Wang Chein-Fu Hung Warner K Huh Cornelia L Trimble Richard B S Roden

Persistent infection by one of 15 high-risk human papillomavirus (hrHPV) types is a necessary but not sufficient cause of 5% of all human cancers. This provides a remarkable opportunity for cancer prevention via immunization. Since Harald zur Hausen's pioneering identification of hrHPV types 16 and 18, found in approximately 50% and 20% of cervical cancers, respectively, two prophylactic HPV va...

2015
Jorge Meléndez Zajgla Vicente Madrid-Marina Eduardo Guzmán Olea Kirvis Janneth Torres-Poveda

In this Chapter we will discuss the current status of the prophylactic HPV vaccination, the introduction of HPV prophylactic vaccination and its impact on the cervical cancer incidence and mortality, challenges of the HPV vaccination in the developing world, screening post vaccination and the secondgeneration HPV prophylactic vaccines, as well as, the development of new therapeutic vaccines and...

2015
Xiao-Xian Xu Jian-Song Zhou Shu-Hui Yuan Hua Yu Han-Mei Lou Paul B. Tchounwou

Human papillomavirus (HPV) are firmly established as the principal causative agent for cervical carcinoma. Current vaccines may provide some protection for women from cervical carcinoma linked to HPV genotype 16 and 18. This may be the best vaccine for Western women, but the geographical variation in HPV distributions may not make it the most appropriate vaccine for China or Asia. This study pr...

2016
Sonia Menon Aibibula Wusiman Marie Claude Boily Mbabazi Kariisa Hillary Mabeya Stanley Luchters Frode Forland Rodolfo Rossi Steven Callens Davy vanden Broeck

BACKGROUND There is a scarcity of data on the distribution of human papillomavirus (HPV) genotypes in the HIV positive population and in invasive cervical cancer (ICC) in Kenya. This may be different from genotypes found in abnormal cytology. Yet, with the advent of preventive HPV vaccines that target HPV 16 and 18, and the nonavalent vaccine targeting 90% of all ICC cases, such HPV genotype di...

2014
Raúl Peralta Cruz Vargas de León Augusto Cabrera Pedro Miramontes

Human papillomavirus (HPV) has been identified as the main etiological factor in the developing of cervical cancer (CC). This finding has propitiated the development of vaccines that help to prevent the HPVs 16 and 18 infection. Both genotypes are associated with 70% of CC worldwide. In the present study, we aimed to determine the emergence of high-risk nonvaccine HPV after actual vaccination s...

2014
Patrizia Vici Luciano Mariani Laura Pizzuti Domenico Sergi Luigi Di Lauro Enrico Vizza Federica Tomao Silverio Tomao Claudia Cavallotti Francesca Paolini Aldo Venuti

Development of HPV-associated cancers not only depends on efficient negative regulation of cell cycle control that supports the accumulation of genetic damage, but also relies on immune evasion that enable the virus to go undetected for long periods of time. In this way, HPV-related tumors usually present MHC class I down-regulation, impaired antigen-processing ability, avoidance of T-cell medi...

Journal: :Vaccine 2007
Sven-Eric Olsson Luisa L Villa Ronaldo L R Costa Carlos A Petta Rosires P Andrade Christian Malm Ole-Erik Iversen John Høye Margareta Steinwall Grete Riis-Johannessen Agneta Andersson-Ellstrom Kristina Elfgren Geo von Krogh Matti Lehtinen Jorma Paavonen Gretchen M Tamms Katherine Giacoletti Lisa Lupinacci Mark T Esser Scott C Vuocolo Alfred J Saah Eliav Barr

BACKGROUND The duration of protection afforded by vaccines represents a critical test of their utility as public health interventions. Some vaccines induce long-term immunity, while others require booster doses. Vaccines that induce long-term protection are usually characterized by the generation of immune memory. Recent trials of a quadrivalent (types 6, 11, 16, 18) human papillomavirus (HPV) ...

Journal: :Lancet 2016
Kathleen M Schmeler Erich M Sturgis

1798 www.thelancet.com Vol 387 April 30, 2016 Human papillomavirus (HPV) is the most common sexually transmitted infection. It aff ects 80% of the population, with the initial infection usually occurring between 15 and 24 years of age. Persistent infection with high-risk oncogenic HPV genotypes, primarily types 16 and 18, is the cause of almost all cervical cancers. HPV is also thought to cause...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید